Metalloprotease type III effectors that specifically cleave JNK and NF-κB

EMBO Journal

Volumn 30, Issue 1, 2011, Pages 221-231

  Baruch, Kobi ^a   Gur Arie, Lihi ^a   Nadler, Chen ^a   Koby, Simi ^a   Yerushalmi, Gal ^a   Ben Neriah, Yinon ^a   Yogev, Orli ^a   Shaulian, Eitan ^a   Guttman, Chen ^b   Zarivach, Raz ^b   Rosenshine, Ilan ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

enteropathogenic E. coli; JNK; NF B; NleC; NleD

Indexed keywords

AP 1 PROTEIN; BACTERIAL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; METALLOPROTEINASE; METALLOPROTEINASE TYPE III; NLEB PROTEIN; NLEC PROTEIN; NLED PROTEIN; NLEE PROTEIN; PROTEINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ZINC;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME SPECIFICITY; FLOW CYTOMETRY; HOST CELL; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; TYPE III SECRETION SYSTEM;

APOPTOSIS; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 9; NF-KAPPA B; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI;

EID: 78650875210     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.297     Document Type: Article

References (40)

1. Auerbuch V, Golenbock DT, Isberg RR (2009) Innate immune recognition of Yersinia pseudotuberculosis type III secretion. PLoS Pathog 5: e1000686
2. Barkett M, Gilmore TD (1999) Control of apoptosis by Rel/ NF-kappaB transcription factors. Oncogene 18: 6910-6924
3. Chen FE, Huang DB, Chen YQ, Ghosh G (1998a) Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature 391: 410-413
4. Chen YQ, Ghosh S, Ghosh G (1998b) A novel DNA recognition mode by the NF-kappa B p65 homodimer. Nat Struct Biol 5: 67-73
5. Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758-765
6. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645
7. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252
8. Dean P, Kenny B (2009) The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol 12: 101-109
9. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ (1994) JNK1: a protein kinase stimulated by UV light and HaRas that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037
10. Doyle SL, O'Neill LA (2006) Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72: 1102-1113
11. Dziva F, van Diemen PM, Stevens MP, Smith AJ, Wallis TS (2004) Identification of Escherichia coli O157:H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis. Microbiology 150: 3631-3645
12. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumor-igenesis. Nat Rev Cancer 3: 859-868
13. Gao X, Wan F, Mateo K, Callegari E, Wang D, Deng W, Puente J, Li F, Chaussee MS, Finlay BB, Lenardo MJ, Hardwidge PR (2009) Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog 5: e1000708
14. Hemrajani C, Berger CN, Robinson KS, Marches O, Mousnier A, Frankel G (2010) NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci USA 107 : 3129-3134
15. Hibi M, Lin A, Smeal T, Minden A, Karin M (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135-2148
16. Iguchi A, Thomson NR, Ogura Y, Saunders D, Ooka T, Henderson IR, Harris D, Asadulghani M, Kurokawa K, Dean P, Kenny B, Quail MA, Thurston S, Dougan G, Hayashi T, Parkhill J, Frankel G (2009) Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191: 347-354
17. Jandhyala DM, Rogers TJ, Kane A, Paton AW, Paton JC, Thorpe CM (2010) Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation. Infect Immun 78: 2984-2994
18. Jijon HB, Panenka WJ, Madsen KL, Parsons HG (2002) MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. Am J Physiol Cell Physiol 283: C31-C41
19. Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, Davis R, Karin M (1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 8: 2996-3007
20. Kang SS, Woo SS, Im J, Yang JS, Yun CH, Ju HR, Son CG, Moon EY, Han SH (2007) Human placenta promotes IL-8 expression through activation of JNK/SAPK and transcription factors NF-kappaB and AP-1 in PMA-differentiated THP-1 cells. Int Immunopharmacol 7: 1488-1495
21. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitina-tion: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663
22. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13: 816-825
23. Kucharczak J, Simmons MJ, Fan Y, Gelinas C (2003) To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961-8982
24. Marches O, Wiles S, Dziva F, La Ragione RM, Schuller S, Best A, Phillips AD, Hartland EL, Woodward MJ, Stevens MP, Frankel G (2005) Characterization of two non-locus of enterocyte efface-ment-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect Immun 73: 8411-8417
25. Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, Warren SE, Leaf IA, Aderem A (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA 107: 3076-3080
26. Nadler C, Baruch K, Kobi S, Mills E, Haviv G, Farago M, Alkalay I, Bartfeld S, Meyer TF, Ben-Neriah Y, Rosenshine I (2010) The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog 6: e1000743
27. Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, Wagstaff KM, Dunstone MA, Sloan J, Whisstock JC, Kaper JB, Robins-Browne RM, Jans DA, Frankel G, Phillips AD, Coulson BS, Hartland EL (2010) The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog 6: e1000898
28. Renzing J, Lane DP (1995) p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts. Oncogene 10: 1865-1868
29. Roger T, Out T, Mukaida N, Matsushima K, Jansen H, Lutter R (1998) Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem J 330 (Part 1): 429-435
30. Ruchaud-Sparagano MH, Maresca M, Kenny B (2007) Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol 9: 1909-1921
31. Shames SR, Deng W, Guttman JA, de Hoog CL, Li Y, Hardwidge PR, Sham HP, Vallance BA, Foster LJ, Finlay BB (2010) The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling. Cell Microbiol 12: 1322-1339
32. Shao F, Golstein C, Ade J, Stoutemyer M, Dixon JE, Innes RW (2003) Cleavage of Arabidopsis PBS1 by a bacterial type III effector. Science 301: 1230-1233
33. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400
34. Takeuchi O, Akira S (2001) Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1: 625-635
35. Toledano MB, Ghosh D, Trinh F, Leonard WJ (1993) N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65. Mol Cell Biol 13: 852-860
36. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874
37. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben-Neriah Y (1998) Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 396: 590-594
38. Yogev O, Anzi S, Inoue K, Shaulian E (2006) Induction of tran-scriptionally active Jun proteins regulates drug-induced senescence. J Biol Chem 281: 34475-34483
39. Yogev O, Saadon K, Anzi S, Inoue K, Shaulian E (2008) DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway. Cancer Res 68: 1398-1406
40. Yu Y, Zeng H, Lyons S, Carlson A, Merlin D, Neish AS, Gewirtz AT (2003) TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am J Physiol Gastrointest Liver Physiol 285: G282-G290